Glenmark Specialty S.a.

Glenmark Pharmaceuticals Limited

Rajesh Ankam

Ulhas R Dhuppad

Chandrakant Dhatrak

Ashok Katkurwar

Yashwant Gupta

Neelima Khairatkar-Joshi

Abhay Kulkarni

Vikram Mansingh Bhosale

Piyush Agarwal

Patrick Keohane

Sudeesh K Tantry

Chad Oh

Dinesh Pradeep Wale

A nasal dispensing device and pharmaceutical composition includes a container; a dispenser head having at least a pump, a dispensing channel, and a dispensing orifice; a dip tube; and a pharmaceutical composition comprising mometasone, an ester thereof (e.g., mometasone furoate), or a salt thereof and olopatadine or its salt (e.g., olopatadine hydrochloride). The container can have a conically shaped internal bottom, angled downwardly toward a center, and a further angularly deepened well, centrally located, with the dip tube extending into the well. An optional cap is provided that includes a sealing sleeve communicating in a seal tight manner with a perimeter of a lateral wall of the dispenser head.

Dispensing device and pharmaceutical composition for the treatment of rhinitis

The present invention relates to a stable fixed dose aqueous pharmaceutical composition (e.g., contained in a container) for nasal administration to a human, comprising mometasone or its salt, olopatadine or its salt. The composition may further include a hydrocolloid. The invention also relates to a process for preparing the pharmaceutical composition, and the use of the pharmaceutical composition in the treatment of rhinitis in a subject.

Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine

Growing community of inventors

Maharashtra, India

Rajesh Ankam